Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

Clinical trial NCT02092389 · TERMINATED

Trial details

NCT number: NCT02092389
Sponsor: AbbVie
Status: TERMINATED
Study type: OBSERVATIONAL

Moderate to Severe Ulcerative Colitis

Start date: 2014-07-01
Primary completion: 2015-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.